Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort

Primary Sjögren's Syndrome (pSS) Clinical Trial

— DIApSS  

Official title:

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03681964
• Other study ID #: DIApSS
• Status: Recruiting
• Start date: September 28, 2015
• Est. completion date: September 28, 2030

Study information

• Verified date: July 2018
• Source: University Hospital, Brest
• Contact: Valerie Devauchelle, MD,PhD
• Phone: 33 (0) 2 98 34 72 64
• Email: valerie.devauchelle-pensec[@]chu-brest.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to evaluate the diagnosis performance of several item used for the classification, the diagnosis and the prognostic of pSS (primary Sjogren syndrome)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 28, 2030
• Est. primary completion date: September 28, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with suspected pSS underwent a standardised evaluation

Exclusion Criteria:

• Opposition of patient

Related Conditions & MeSH terms

• Primary Sjögren's Syndrome (pSS)
• Sjogren's Syndrome
• Syndrome

Locations

Country	Name	City	State
France	CHRU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	classification criteria	classification criteria at inclusion of patients with suspected primary Sjögren's syndrome (pSS) underwent with standardised evaluation	Inclusion (Day 0)